These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29734149)

  • 1. Recent Advances in Treatment Strategies for Lupus Nephritis.
    Karasawa K; Uchida K; Takabe T; Moriyama T; Nitta K
    Contrib Nephrol; 2018; 195():42-50. PubMed ID: 29734149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
    Fanouriakis A; Kostopoulou M; Cheema K; Anders HJ; Aringer M; Bajema I; Boletis J; Frangou E; Houssiau FA; Hollis J; Karras A; Marchiori F; Marks SD; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; van Vollenhoven RF; Voskuyl AE; Teng YKO; van Leew B; Bertsias G; Jayne D; Boumpas DT
    Ann Rheum Dis; 2020 Jun; 79(6):713-723. PubMed ID: 32220834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
    Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment.
    Reis-Neto ETD; Seguro LPC; Sato EI; Borba EF; Klumb EM; Costallat LTL; Medeiros MMDC; Bonfá E; Araújo NC; Appenzeller S; Montandon ACOES; Yuki EFN; Teixeira RCA; Telles RW; Egypto DCSD; Ribeiro FM; Gasparin AA; Junior ASA; Neiva CLS; Calderaro DC; Monticielo OA
    Adv Rheumatol; 2024 Jun; 64(1):48. PubMed ID: 38890752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.
    Groot N; de Graeff N; Marks SD; Brogan P; Avcin T; Bader-Meunier B; Dolezalova P; Feldman BM; Kone-Paut I; Lahdenne P; McCann L; Özen S; Pilkington CA; Ravelli A; Royen-Kerkhof AV; Uziel Y; Vastert BJ; Wulffraat NM; Beresford MW; Kamphuis S
    Ann Rheum Dis; 2017 Dec; 76(12):1965-1973. PubMed ID: 28877866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis.
    Basu B; Roy B; Babu BG
    Pediatr Nephrol; 2017 Jun; 32(6):1013-1021. PubMed ID: 28191596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Mok CC
    Nephrol Dial Transplant; 2016 Oct; 31(10):1561-6. PubMed ID: 27591327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.
    Tian SY; Feldman BM; Beyene J; Brown PE; Uleryk EM; Silverman ED
    J Rheumatol; 2014 Oct; 41(10):1998-2007. PubMed ID: 25225281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
    Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M
    Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Lupus Nephritis: Core Curriculum 2020.
    Parikh SV; Almaani S; Brodsky S; Rovin BH
    Am J Kidney Dis; 2020 Aug; 76(2):265-281. PubMed ID: 32220510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Kronbichler A; Neumann I; Mayer G
    Nephrol Dial Transplant; 2016 Oct; 31(10):1572-6. PubMed ID: 27591329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
    Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
    Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
    Mok CC; Ho LY; Ying SKY; Leung MC; To CH; Ng WL
    Ann Rheum Dis; 2020 Aug; 79(8):1070-1076. PubMed ID: 32448782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis.
    Kawazoe M; Nanki T
    Lupus; 2024 Apr; 33(4):319-327. PubMed ID: 38232223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and maintenance therapy in proliferative lupus nephritis.
    Ponticelli C; Glassock RJ; Moroni G
    J Nephrol; 2010; 23(1):9-16. PubMed ID: 20091481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB; Won S; Bae SC
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil for lupus nephritis: an update.
    Mok CC
    Expert Rev Clin Immunol; 2015; 11(12):1353-64. PubMed ID: 26364748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab use as induction therapy for lupus nephritis: a systematic review.
    Stolyar L; Lahita RG; Panush RS
    Lupus; 2020 Jul; 29(8):892-912. PubMed ID: 32486934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.